AstraZeneca PLC (ZEG)
FSX
143.45
+3.25 (+2.32%)
Closed
Oct 7, 2026
Day's Range
138.90143.45
52 wk Range
134.00180.45
Financial Statements - ZEG - AstraZeneca PLC
Revenue
58.73B▲ 28.4%
Net Income
10.23B▲ 71.8%Net Margin 17.4%
EBITDA
19.13B▲ 45.1%
Free Cash Flow
8.67B▲ 40.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 58.73B | 45.75B | 45.81B | 44.35B | 37.41B | 26.61B |
| Cost of Goods | 10.63B | 8.63B | 8.26B | 12.39B | 12.43B | 5.29B |
| Gross Profit | 48.10B | 37.11B | 37.54B | 31.96B | 24.98B | 21.31B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 13.32B | 8.67B | 8.72B | 4.51B | -139M | 3.91B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 12.40B | 7.35B | 6.89B | 2.50B | -265M | 3.91B |
| Income Tax | 2.16B | 1.39B | 938M | -792M | -380M | 772M |
| Net Income | 10.23B | 5.95B | 5.96B | 3.29B | 115M | 3.14B |
| EPS Basic | 6.6 | 4.54 | 3.84 | 2.12 | 0.08 | 2.44 |
| EPS Diluted | 6.54 | 4.5 | 3.81 | 2.11 | 0.08 | 2.44 |
| Basic Shares Outstanding | 1.55B | 1.31B | 1.59B | 1.58B | 1.45B | 1.34B |
| Diluted Shares Outstanding | 1.55B | 1.31B | 1.59B | 1.58B | 1.45B | 1.34B |
| Ebit | 14.01B | 8.77B | 8.48B | 3.83B | 1.01B | 5.18B |
| Ebitda | 19.13B | 13.19B | 13.91B | 9.82B | 3.92B | 6.83B |
| Net Income Continuous Operations | 12.40B | 7.35B | 6.89B | 2.50B | -265M | 3.91B |
| Minority Interests | -8M | -6M | -6M | -5M | -3M | 52M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
